Advate 250 IE (5 ml), Pulver und Lösungsmittel zur Herstellung einer Injektionslösung - Set(s) Swissmedic Key 56352001 Registration Holder Takeda Pharma AG Name Advate 250 IE (5 ml), Pulver und Lösungsmittel zur Herstellung einer Injektionslösung Date of registration 17.02.2004 Introduction of Sequence 17.02.2004 ATC-Classification Coagulation Factor Viii (B02BD02) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 06.01.10. Show package size Set(s) Index Therapeuticus (Swissmedic) 06.01.10. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price 321.25 Deductible k.A. Consumer price 361.25 Feedback FB GTIN 7680563520011 Medication Code Biotechnologika Pharmacode Disponibility
Composition Praeparatio cryodesiccata: octocogum alfa 250 U.I., trehalosum dihydricum, histidinum, trometamolum, natrii chloridum corresp. natrium 10.35 mg, calcii chloridum dihydricum, polysorbatum 80, mannitolum, glutathionum, pro vitro.
Solvens: aqua ad iniectabile 5 ml. Packungsbestandteile Label Praeparatio cryodesiccata:
Galenic Form Lyophilisate and solvent Excipiens Active Agent Dose Blutgerinnungsfaktor Viii Vom Menschen 250 UI
Inactive agents Calcium Chloride Glutathionum Histidine Mannitol Sodium Chloride Polysorbatum 80 Trehalosum Dihydricum Trometamol
Source Data was imported : 11.07.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
